DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

Hepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the hos...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanmeng Chen, Bocun Shen, Xiaochuan Zheng, Quanxin Long, Jie Xia, Yao Huang, Xuefei Cai, Deqiang Wang, Juan Chen, Ni Tang, Ailong Huang, Yuan Hu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1725398
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850200388159930368
author Yanmeng Chen
Bocun Shen
Xiaochuan Zheng
Quanxin Long
Jie Xia
Yao Huang
Xuefei Cai
Deqiang Wang
Juan Chen
Ni Tang
Ailong Huang
Yuan Hu
author_facet Yanmeng Chen
Bocun Shen
Xiaochuan Zheng
Quanxin Long
Jie Xia
Yao Huang
Xuefei Cai
Deqiang Wang
Juan Chen
Ni Tang
Ailong Huang
Yuan Hu
author_sort Yanmeng Chen
collection DOAJ
description Hepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the host factors involved in the process of regulating the anti-HBV function of A3B are less known. In this research, to obtain a comprehensive understanding of the interaction networks of A3B, we conducted coimmunoprecipitation and mass spectrometry to identify A3B-interacting proteins in the presence of HBV. By this approach, we determined that DExD/H-box helicase 9 (DHX9) suppressed the anti-HBV effect of A3B, and this suppression was dependent on their interaction. Although DHX9 did not affect the deamination activity of A3B in vitro assay or the viral DNA editing of A3B in HepG2-NTCP cells that support HBV infection, it inhibited the binding of A3B with pgRNA. These data suggest that DHX9 can interact with A3B and attenuate the anti-HBV efficacy of A3B.Abbreviations: 3D-PCR: differential DNA denaturation PCR; APOBEC3: apolipoprotein B mRNA-editing catalytic polypeptide 3; cccDNA: covalently closed circular DNA; co-IP: coimmunoprecipitation; DDX: DExD-box RNA helicases; HBc: HBV core protein; HBV: hepatitis B virus; HepAD38: HepG2 cell line stably transfected with HBV DNA; HepG2-NTCP: HepG2 cell line stably transfected with Na+/taurocholate cotransporter polypeptide; Huh7: human hepatoma cell line; pgRNA: pregenomic RNA; PPI: protein–protein interactions; RC DNA: relaxed circular DNA.
format Article
id doaj-art-3c2c19292d6948d381b47b30b44dee2c
institution OA Journals
issn 2222-1751
language English
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-3c2c19292d6948d381b47b30b44dee2c2025-08-20T02:12:20ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019136637710.1080/22221751.2020.1725398DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3BYanmeng Chen0Bocun Shen1Xiaochuan Zheng2Quanxin Long3Jie Xia4Yao Huang5Xuefei Cai6Deqiang Wang7Juan Chen8Ni Tang9Ailong Huang10Yuan Hu11Key Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaKey Laboratory of Molecular Biology on Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaHepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the host factors involved in the process of regulating the anti-HBV function of A3B are less known. In this research, to obtain a comprehensive understanding of the interaction networks of A3B, we conducted coimmunoprecipitation and mass spectrometry to identify A3B-interacting proteins in the presence of HBV. By this approach, we determined that DExD/H-box helicase 9 (DHX9) suppressed the anti-HBV effect of A3B, and this suppression was dependent on their interaction. Although DHX9 did not affect the deamination activity of A3B in vitro assay or the viral DNA editing of A3B in HepG2-NTCP cells that support HBV infection, it inhibited the binding of A3B with pgRNA. These data suggest that DHX9 can interact with A3B and attenuate the anti-HBV efficacy of A3B.Abbreviations: 3D-PCR: differential DNA denaturation PCR; APOBEC3: apolipoprotein B mRNA-editing catalytic polypeptide 3; cccDNA: covalently closed circular DNA; co-IP: coimmunoprecipitation; DDX: DExD-box RNA helicases; HBc: HBV core protein; HBV: hepatitis B virus; HepAD38: HepG2 cell line stably transfected with HBV DNA; HepG2-NTCP: HepG2 cell line stably transfected with Na+/taurocholate cotransporter polypeptide; Huh7: human hepatoma cell line; pgRNA: pregenomic RNA; PPI: protein–protein interactions; RC DNA: relaxed circular DNA.https://www.tandfonline.com/doi/10.1080/22221751.2020.1725398Hepatitis B virusAPOBEC3BDHX9interactionattenuate
spellingShingle Yanmeng Chen
Bocun Shen
Xiaochuan Zheng
Quanxin Long
Jie Xia
Yao Huang
Xuefei Cai
Deqiang Wang
Juan Chen
Ni Tang
Ailong Huang
Yuan Hu
DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
Emerging Microbes and Infections
Hepatitis B virus
APOBEC3B
DHX9
interaction
attenuate
title DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
title_full DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
title_fullStr DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
title_full_unstemmed DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
title_short DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
title_sort dhx9 interacts with apobec3b and attenuates the anti hbv effect of apobec3b
topic Hepatitis B virus
APOBEC3B
DHX9
interaction
attenuate
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1725398
work_keys_str_mv AT yanmengchen dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT bocunshen dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT xiaochuanzheng dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT quanxinlong dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT jiexia dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT yaohuang dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT xuefeicai dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT deqiangwang dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT juanchen dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT nitang dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT ailonghuang dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b
AT yuanhu dhx9interactswithapobec3bandattenuatestheantihbveffectofapobec3b